Fresenius Medical Care AG KGaA Operating Income 2010-2024 | FMS

Fresenius Medical Care AG KGaA annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Fresenius Medical Care AG KGaA operating income for the quarter ending September 30, 2024 was $0.509B, a 44.18% increase year-over-year.
  • Fresenius Medical Care AG KGaA operating income for the twelve months ending September 30, 2024 was $1.694B, a 22.1% increase year-over-year.
  • Fresenius Medical Care AG KGaA annual operating income for 2023 was $1.482B, a 6.95% decline from 2022.
  • Fresenius Medical Care AG KGaA annual operating income for 2022 was $1.593B, a 27.32% decline from 2021.
  • Fresenius Medical Care AG KGaA annual operating income for 2021 was $2.191B, a 16.75% decline from 2020.
Fresenius Medical Care AG KGaA Annual Operating Income
(Millions of US $)
2023 $1,482
2022 $1,593
2021 $2,191
2020 $2,632
2019 $2,542
2018 $3,588
2017 $2,670
2016 $2,638
2015 $2,327
2014 $2,255
2013 $2,230
2012 $2,165
2011 $2,044
2010 $1,924
2009 $1,756
Fresenius Medical Care AG KGaA Quarterly Operating Income
(Millions of US $)
2024-09-30 $509
2024-06-30 $457
2024-03-31 $267
2023-12-31 $460
2023-09-30 $353
2023-06-30 $389
2023-03-31 $280
2022-12-31 $365
2022-09-30 $475
2022-06-30 $362
2022-03-31 $390
2021-12-31 $513
2021-09-30 $595
2021-06-30 $511
2021-03-31 $572
2020-12-31 $559
2020-09-30 $739
2020-06-30 $722
2020-03-31 $612
2019-12-31 $685
2019-09-30 $662
2019-06-30 $586
2019-03-31 $609
2018-12-31 $694
2018-09-30 $612
2018-06-30 $1,671
2018-03-31 $611
2017-12-31 $619
2017-09-30 $715
2017-06-30 $642
2017-03-31 $694
2016-12-31 $786
2016-09-30 $670
2016-06-30 $641
2016-03-31 $540
2015-12-31 $662
2015-09-30 $614
2015-06-30 $547
2015-03-31 $504
2014-12-31 $663
2014-09-30 $590
2014-06-30 $556
2014-03-31 $445
2013-12-31 $659
2013-09-30 $551
2013-06-30 $532
2013-03-31 $487
2012-12-31 $554
2012-09-30 $562
2012-06-30 $560
2012-03-31 $488
2011-12-31 $578
2011-09-30 $528
2011-06-30 $501
2011-03-31 $438
2010-12-31 $542
2010-09-30 $493
2010-06-30 $465
2010-03-31 $424
2009-12-31 $491
2009-09-30 $451
2009-06-30 $418
2009-03-31 $396
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $13.192B $21.053B
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $197.634B 24.11
Intuitive Surgical (ISRG) United States $186.606B 97.56
Edwards Lifesciences (EW) United States $43.604B 27.69
Alcon (ALC) Switzerland $41.521B 27.78
IQVIA Holdings (IQV) United States $34.761B 19.15
IDEXX Laboratories (IDXX) United States $33.493B 39.44
DexCom (DXCM) United States $29.615B 44.60
Waters (WAT) United States $21.413B 31.66
STERIS (STE) Ireland $20.170B 23.22
SONOVA HOLDING (SONVY) Switzerland $19.359B 0.00
Hologic (HOLX) United States $16.058B 17.34
Sysmex ADR (SSMXY) Japan $11.726B 36.77
Globus Medical (GMED) United States $11.158B 28.25
Penumbra (PEN) United States $9.346B 91.55
Masimo (MASI) United States $9.102B 44.04
Teleflex (TFX) United States $8.118B 12.95
Glaukos (GKOS) United States $7.925B 0.00
Integer Holdings (ITGR) United States $4.457B 25.26
PROCEPT BioRobotics (PRCT) United States $4.215B 0.00
Inari Medical (NARI) United States $3.185B 0.00
Veracyte (VCYT) United States $3.028B 90.86
Nihon Kohden (NHNKY) Japan $2.590B 19.67
LivaNova (LIVN) United Kingdom $2.579B 14.89
Tandem Diabetes Care (TNDM) United States $2.185B 0.00
Elekta AB (EKTAY) Sweden $2.096B 18.84
TransMedics (TMDX) United States $2.031B 64.39
Integra LifeSciences Holdings (IART) United States $1.675B 8.75
RxSight (RXST) United States $1.539B 0.00
Alphatec Holdings (ATEC) United States $1.255B 0.00
Artivion (AORT) United States $1.173B 77.69
Pulse Biosciences (PLSE) United States $1.094B 0.00
OPKO Health (OPK) United States $1.072B 0.00
Paragon 28 (FNA) United States $0.820B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.760B 12.92
Mesa Laboratories (MLAB) United States $0.714B 16.83
IRadimed (IRMD) United States $0.676B 36.54
ORTHOFIX MEDICAL INC (OFIX) United States $0.657B 0.00
AxoGen (AXGN) United States $0.654B 0.00
Semler Scientific (SMLR) United States $0.568B 29.92
SiBone (SIBN) United States $0.547B 0.00
OrthoPediatrics (KIDS) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
Treace Medical Concepts (TMCI) United States $0.430B 0.00
Tactile Systems Technology (TCMD) United States $0.407B 22.01
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.357B 0.00
AngioDynamics (ANGO) United States $0.349B 0.00
NeuroPace (NPCE) United States $0.333B 0.00
CVRx (CVRX) United States $0.284B 0.00
Alpha Tau Medical (DRTS) Israel $0.219B 0.00
Inogen (INGN) United States $0.198B 0.00
Accuray (ARAY) United States $0.180B 0.00
Sight Sciences (SGHT) United States $0.171B 0.00
KORU Medical Systems (KRMD) United States $0.170B 0.00
Nevro (NVRO) United States $0.135B 0.00
Atossa Genetics (ATOS) United States $0.123B 0.00
Sensus Healthcare (SRTS) United States $0.118B 12.65
Spectral Diagnostics (EDTXF) Canada $0.094B 0.00
LENSAR (LNSR) United States $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.086B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Vicarious Surgical (RBOT) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
908 Devices (MASS) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.066B 0.00
WORK Medical Technology Group (WOK) China $0.058B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.044B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Neuronetics (STIM) United States $0.039B 0.00
Envoy Medical (COCH) United States $0.037B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.008B 0.00
T2 Biosystems (TTOO) United States $0.007B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Check-Cap (CHEK) Israel $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00